BioSante announces demonstration of LibiGel safety upgrade at ENDO 2010 BioSante Pharmaceuticals comment ça marche.

BioSante announces demonstration of LibiGel safety upgrade at ENDO 2010 BioSante Pharmaceuticals, Inc. , will show a LibiGel safety revise at the 2010 Annual Getting together with of the Endocrine Culture , being kept from June 19-22, 2010 in NORTH PARK, California. Snabes, MD, PhD, BioSante’s vice president of clinical development, gives a demonstration entitled, ‘Low Cardiovascular Event Price in Post-menopausal Females with an increase of Cardiac Risk: Results from the Ongoing Blinded LibiGel Cardiovascular and Breast Cancer Security Study,on Sunday June 20 ‘, 2010 comment ça marche . The update includes the full total results of the 3rd unblinded overview of safety data, including 1,500 women-years of exposure, by the independent Data Monitoring Committee of the LibiGel Cardiovascular and Breasts Cancer Safety Study.